Levotofisopam
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Levotofisopam, covering 2012-01-27 to 2012-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout [Phase 2]